204 related articles for article (PubMed ID: 36634119)
1. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020).
Yang L; Boily MC; Rönn MM; Obiri-Yeboah D; Morhason-Bello I; Meda N; Lompo O; Mayaud P; Pickles M; Brisson M; Hodgins C; Delany-Moretlwe S; Maheu-Giroux M
PLoS Med; 2023 Jan; 20(1):e1004143. PubMed ID: 36634119
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
Asangbeh-Kerman SL; Davidović M; Taghavi K; Kachingwe J; Rammipi KM; Muzingwani L; Pascoe M; Jousse M; Mulongo M; Mwanahamuntu M; Tapela N; Akintade O; Basu P; Dlamini X; Bohlius J
BMC Public Health; 2022 Aug; 22(1):1530. PubMed ID: 35948944
[TBL] [Abstract][Full Text] [Related]
3. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa.
Ibrahim Khalil A; Mpunga T; Wei F; Baussano I; de Martel C; Bray F; Stelzle D; Dryden-Peterson S; Jaquet A; Horner MJ; Awolude OA; Trejo MJ; Mudini W; Soliman AS; Sengayi-Muchengeti M; Coghill AE; van Aardt MC; De Vuyst H; Hawes SE; Broutet N; Dalal S; Clifford GM
Int J Cancer; 2022 Mar; 150(5):761-772. PubMed ID: 34626498
[TBL] [Abstract][Full Text] [Related]
4. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
[TBL] [Abstract][Full Text] [Related]
5. Prenatal care coverage and correlates of HIV testing in sub-Saharan Africa: Insight from demographic and health surveys of 16 countries.
Awopegba OE; Kalu A; Ahinkorah BO; Seidu AA; Ajayi AI
PLoS One; 2020; 15(11):e0242001. PubMed ID: 33166351
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Côte d'Ivoire, West Africa.
Tchounga B; Boni SP; Koffi JJ; Horo AG; Tanon A; Messou E; Koulé SO; Adoubi I; Ekouevi DK; Jaquet A
BMJ Open; 2019 Aug; 9(8):e029882. PubMed ID: 31473620
[TBL] [Abstract][Full Text] [Related]
7. Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening.
Boily MC; Barnabas RV; Rönn MM; Bayer CJ; van Schalkwyk C; Soni N; Rao DW; Staadegaard L; Liu G; Silhol R; Brisson M; Johnson LF; Bloem P; Gottlieb S; Broutet N; Dalal S
EClinicalMedicine; 2022 Dec; 54():101754. PubMed ID: 36583170
[TBL] [Abstract][Full Text] [Related]
8. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
9. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
Mengesha MB; Chekole TT; Hidru HD
BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
Lott BE; Trejo MJ; Baum C; McClelland DJ; Adsul P; Madhivanan P; Carvajal S; Ernst K; Ehiri J
BMC Public Health; 2020 May; 20(1):654. PubMed ID: 32393218
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
Ba DM; Ssentongo P; Musa J; Agbese E; Diakite B; Traore CB; Wang S; Maiga M
Cancer Epidemiol; 2021 Jun; 72():101930. PubMed ID: 33756434
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
Bruni L; Serrano B; Roura E; Alemany L; Cowan M; Herrero R; Poljak M; Murillo R; Broutet N; Riley LM; de Sanjose S
Lancet Glob Health; 2022 Aug; 10(8):e1115-e1127. PubMed ID: 35839811
[TBL] [Abstract][Full Text] [Related]
15. Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data.
Giguère K; Eaton JW; Marsh K; Johnson LF; Johnson CC; Ehui E; Jahn A; Wanyeki I; Mbofana F; Bakiono F; Mahy M; Maheu-Giroux M
Lancet HIV; 2021 May; 8(5):e284-e293. PubMed ID: 33667411
[TBL] [Abstract][Full Text] [Related]
16. Temporal Trends and Determinants of HIV Testing at Antenatal Care in Sub-Saharan Africa: A Pooled Analysis of Population-Based Surveys (2005-2021).
Allorant A; Muset P; Hodgins C; Kirakoya-Samadoulougou F; Namachapa K; Mbofana F; Panagiotoglou D; Johnson LF; Imai-Eaton JW; Maheu-Giroux M
J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e97-e105. PubMed ID: 38180847
[TBL] [Abstract][Full Text] [Related]
17. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
18. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
19. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.
Lemp JM; De Neve JW; Bussmann H; Chen S; Manne-Goehler J; Theilmann M; Marcus ME; Ebert C; Probst C; Tsabedze-Sibanyoni L; Sturua L; Kibachio JM; Moghaddam SS; Martins JS; Houinato D; Houehanou C; Gurung MS; Gathecha G; Farzadfar F; Dryden-Peterson S; Davies JI; Atun R; Vollmer S; Bärnighausen T; Geldsetzer P
JAMA; 2020 Oct; 324(15):1532-1542. PubMed ID: 33079153
[TBL] [Abstract][Full Text] [Related]
20. Determinants of cervical cancer screening among women living with HIV in Zimbabwe.
Antabe R; Luginaah NA; Kangmennaang J; Mkandawire P
Health Promot Int; 2023 Aug; 38(4):. PubMed ID: 37440254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
